We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BV3 market cap is 1.82B. The company's latest EPS is DKK 18.8890 and P/E is 1.27.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 662.49M | 1.85B | 1.9B | 3.15B | 7.06B |
| Operating Income | -328.45M | 382.74M | -308.29M | -69.61M | 1.5B |
| Net Income | -346.78M | 277.52M | -464.78M | -347.38M | 1.48B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 7.05B | 8.76B | 12.09B | 12.39B | 14.35B |
| Total Liabilities | 5.18B | 3.86B | 4.71B | 5.24B | 4.01B |
| Total Equity | 1.87B | 4.89B | 7.37B | 7.15B | 10.34B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | -275.91M | 571.91M | -358.5M | 220.05M | 1.12B |
| Investing | -809.94M | -1.91B | -2.88B | -877.41M | -945.56M |
| Financing | 1.11B | 1.33B | 3.54B | 635.82M | 735.83M |
| Market Cap | 1.82B |
| Price to Earnings Ratio | 1.27 |
| Price to Sales Ratio | 0.27 |
| Price to Cash Ratio | 1.27 |
| Price to Book Ratio | 0.18 |
| Dividend Yield | - |
| Shares Outstanding | 78.1M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.22 (0.94%) |
| Company Name | Bavarian Nordic AS |
| Address |
hejreskovvej 10a kvistgaard DK-3490 |
| Website | https://www.bavarian-nordic.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
